Purpose Although obesity is associated with numerous diseases, the risks of disease may depend on metabolically healthy status. Nevertheless, it is unclear to whether metabolically healthy status affects risk of gastrointestinal (GI) cancer in general Chinese population.
Materials and Methods A total of 114,995 participants who met the criteria were included from the Kailuan Study. The study participants were divided into four groups according to body mass index (BMI)/waist circumference (WC) and metabolic status. Incident of GI cancer (esophageal cancer, gastric cancer, liver cancer, biliary cancer, pancreatic cancer, and colorectal cancer) during 2006-2020 were confirmed by review of medical records. The Cox proportional hazard regression models were used to assess the association metabolically healthy status with the risk of GI cancer by calculating the hazard ratios (HR) and 95% confidence interval (CI).
Results During a mean 13.76 years of follow-up, we documented 2,311 GI cancers. Multivariate Cox regression analysis showed that compared with the metabolically healthy normal-weight group, metabolically healthy obese (MHO) participants demonstrated an increased risk of developing GI cancer (HR, 1.54; 95% CI, 1.11 to 2.13) by BMI categories. However, such associations were not found for WC category. These associations were moderated by age, sex, and anatomical site of the tumor. Individuals with metabolic unhealthy normal-weight or metabolic unhealthy obesity phenotype also have an increased risk of GI cancer.
Conclusion MHO phenotype was associated with increased risk of GI cancer. Moreover, individuals who complicated by metabolic unhealthy status have an increased risk of developing GI cancer. Hence, clinicians should consider the risk of incident GI cancer in people with abnormal metabolically healthy status and counsel them about metabolic fitness and weight control.
Citations
Citations to this article as recorded by
Metabolic Phenotype and Risk of Obesity-Related Cancers in the Women’s Health Initiative Prasoona Karra, Sheetal Hardikar, Maci Winn, Garnet L. Anderson, Benjamin Haaland, Aladdin H. Shadyab, Marian L. Neuhouser, Rebecca A. Seguin-Fowler, Cynthia A. Thomson, Mace Coday, Jean Wactawski-Wende, Marcia L. Stefanick, Xiaochen Zhang, Ting-Yuan Davi Cancer Prevention Research.2025; 18(2): 63. CrossRef
Associations of Social Vulnerability and Race‐Ethnicity With Gastrointestinal Cancers in the United States David J. Fei‐Zhang, David J. Bentrem, Jeffrey D. Wayne, Lifang Hou, Peiwen Fei, Timothy M. Pawlik Cancer Medicine.2025;[Epub] CrossRef
Association between metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction subtypes and risk of colorectal cancer: A prospective cohort study Yuan Li, Xiang-ming Ma, Jian-guo Jia, Li-ying Cao Clinics and Research in Hepatology and Gastroenterology.2025; 49(5): 102573. CrossRef
From healthy to unhealthy obesity: A longitudinal study of adults in ELSA-Brasil Fernanda Duarte Mendes, Hully Cantão dos Santos, José Geraldo Mill, Maria Del Carmen Bisi Molina, Maria de Fátima H. Sander Diniz, Carla Romagnolli Quintino, Márcio Sommer Bittencourt, Carolina Perim de Faria, Julia Robinson PLOS Global Public Health.2025; 5(4): e0004325. CrossRef
Association between transitions in metabolic health and colorectal cancer across categories of body size phenotype: a prospective cohort study Qian Liu, Fei Si, Yuntao Wu, Jing Yu Obesity.2024; 32(10): 1948. CrossRef
Gastric Cancer - Epidemiology, Modifiable and Non-modifiable Risk Factors, Challenges and Opportunities: An Updated Review Tajul Islam Mamun, Sabrina Younus, Md. Hashibur Rahman Cancer Treatment and Research Communications.2024; : 100845. CrossRef
Research Progress of Scutellaria baicalensis in the Treatment of Gastrointestinal Cancer Lankang Wang, Baoyi Ni, Jia Wang, Jilai Zhou, Junyi Wang, Jiakang Jiang, Yutong Sui, Yaoyao Tian, Feng Gao, Yufeng Lyu Integrative Cancer Therapies.2024;[Epub] CrossRef